Previous Article | Next Article 
Infection and Immunity, September 2000, p. 5084-5089, Vol. 68, No. 9
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Differential Expression of Caveolin-1 in
Lipopolysaccharide-Activated Murine Macrophages
Mei G.
Lei1,* and
David C.
Morrison1,2,3
Department of Microbiology, Molecular
Genetics and Immunology, University of Kansas Medical Center, Kansas
City, Kansas,1 Office of Research
Administration, St. Luke's Hospital, Kansas City, Missouri
64111,2 and Department of Basic Medical
Science, University of Missouri at Kansas City, School of Medicine,
Kansas City, Missouri 641083
Received 7 April 2000/Accepted 15 June 2000
 |
ABSTRACT |
Five reciprocal cycles of subtractive hybridization using cDNA
generated from fibroblasts with normal lipopolysaccharide (LPS) responsiveness (lpsn) and from hyporesponsive
(lpsd) fibroblasts have led to the finding that
caveolin-1 is expressed at markedly higher levels of mRNA in
lpsd than in lpsn
fibroblasts. Caveolin-1 message can also be readily detected via
reverse transcription-PCR in the RAW264.7 and J774.1 macrophage-like cell lines as well as in primary thioglycolate (TG)-elicited mouse peritoneal macrophages. In RAW264.7 cells, both caveolin-1 mRNA and
protein levels are down-regulated by LPS. In TG-elicited C3HeB/FeJ peritoneal macrophages, in contrast, expression of both caveolin-1 protein and mRNA is up-regulated in vitro in response to LPS
stimulation. The up-regulation of caveolin-1 protein expression in
C3HeB/FeJ peritoneal macrophages can be demonstrated at concentrations
as low as 1.0 pg of LPS/ml. However, LPS concentrations approximately 4 orders of magnitude higher (104 pg/ml) were required to
stimulate the LPS-hyporesponsive C3H/HeJ mice peritoneal macrophages
such that significant caveolin-1 protein up-regulation was detected.
Caveolin-1, a principal component of plasmalemmal caveolae, has been
reported as a potentially important regulator for signal transduction
during cellular stimulation. The results described in this report
suggest that caveolin-1 expression may be associated with LPS
signaling/internalization.
 |
INTRODUCTION |
The mutant inbred mouse strain
C3H/HeJ was first reported in 1965 (4) to manifest an
altered immunologic responsiveness to bacterial products and in 1968 (28) to be unique in its responsiveness to
lipopolysaccharide (LPS) (24). The latter studies
phenotypically defined the lps gene, which controls
responsiveness to LPS. This gene has been mapped to chromosome 4 between the ps (polysyndacty) and mup-1 (major
urinary protein-1) loci (34). Genotypically, the
lps gene can therefore be defined as a "normal"
lpsn allele and a "defective"
lpsd allele. In vitro studies in a variety of
host immune-inflammatory cells have clearly established C3H/HeJ mice to
be hyporesponsive to LPS.
To better understand the mechanism(s) of innate LPS recognition and to
provide insight for potential clinical therapeutic intervention in
gram-negative sepsis, many laboratories, including our own, have
intensively pursued studies in efforts to define the C3H/HeJ molecular
genetic defect. Using transfection of C3H/HeJ splenic B cells with cDNA
produced from lpsn C3H/HeOuJ mice, and
differential functional screening approaches, Kang et al.
(15) were able to isolate a cDNA that has sequence homology to the gene encoding Ran/TC4 GTPase. This gene has
been localized to chromosome 4 and has recently been reported to be mutated in C3H/HeJ mice, which may account for their resistance to
endotoxin-induced lethality (33). In another recent study, by applying differential display analysis of macrophage cell lines derived from C3H/HeJ and C3H/HeN mice, Jin et al. (13, 14) have reported that secretory leukocyte protease inhibitor (SLPI) and
matrix metalloprotease-9 (MMP-9) were constitutively overexpressed in
lpsd but not in lpsn
macrophages. SLPI functions as an LPS-induced LPS response inhibitor, whereas the role of MMP-9 in the LPS response is not known. However, the genes for SLPI and MMP-9 were not mapped to chromosome 4.
More recently, Poltorak et al. (22) and Qureshi et al.
(23), using high-resolution genetic and physical mapping of
the lps allele, came to the same important conclusion: that
C3H/HeJ mice manifest a missense mutation in the coding region of the Toll-like receptor-4 gene (tlr4). Although there are now
reports that would strongly implicate tlr4 as the functional
LPS-responsive gene (1, 5, 12, 20), the actual overall
significance of this gene of the lps allele
(tlr4) for LPS responsiveness remains clouded following the
recently published comprehensive genetic backcross studies of Vogel and
colleagues (31). These investigators clearly demonstrated
that the expression of a normal lpsn allele
(tlr4) molecule is apparently not a prerequisite for LPS sensitivity when the lpsd allele is present in
the hemizygous state. More studies need to be done in order to fully
understand the involvement of Toll-like receptor 4 (TLR4) in LPS
signaling. Nevertheless, this finding raises the challenging question
of precisely which genes whose products contribute to LPS signaling in
concert with TLR4 might be located in regions of the mouse chromosome
other than the long-recognized allele in chromosome 4 but still would
be important to the LPS-responsive phenotype.
C3HeB/FeJ (lpsn) and C3H/HeJ
(lpsd) mice are well recognized to be fully
histocompatible strains (9). We have, therefore, hypothesized that a subtractive cDNA library constructed from the
lpsn and lpsd cells would
be expected to contain clones carrying relevant genes contributing to
LPS responsiveness in cellular signaling. As will be summarized in this
report, we have employed such a subtractive hybridization approach to
identify differentially expressed genes present in two fibroblast cell
lines developed from lpsn and
lpsd mouse strains. These cell lines manifest
the appropriate LPS phenotype, as assayed by interleukin-6 (IL-6)
secretion in response to LPS stimulation. The results of those studies
reported here focus on the caveolin-1 gene, one of the major genes
identified through our extensive molecular analysis of these
subtractive cDNA libraries.
Earlier published studies identified caveolin-1 as a structural marker
protein of the membrane coats of caveolae (8, 25). Caveolae
have been generally defined as non-clathrin-coated plasmalemmal microdomains found in many mammalian cells, and these membrane domains
have been found to be highly enriched in glycosphingolipids, cholesterol, sphingomyelin, and lipid-anchored membrane proteins. Recently, an increasing number of signal transduction molecules have
been discovered to be caveola associated (reviewed in references 21 and 27). For example,
caveolin-1 has been reported to interact with regulatory G-protein
subunits, Ha-Ras, Src family tyrosine kinases, endothelial nitric oxide
synthase (eNOS), epidermal growth factor receptor (EGF-R) (and related
receptor tyrosine kinases), and protein kinase C isoforms.
Interestingly, the activities of eNOS and G-protein
subunits, and
the autoactivation of the Src family tyrosine kinases, have been
reported to be suppressed by caveolin-1 (6).
The caveolin-1 gene is localized to murine chromosome 6, specifically,
in chromosome region 6-A2 (7). Remarkably, much like the
Toll-like family of receptors, which is involved in innate immunity
(11), the caveolin gene family is also structurally and
functionally conserved from Caenorhabditis elegans to humans (29), suggesting an essential and/or critical role of
caveolins in organizing and concentrating signaling molecules within
caveolae. In this report, we describe results that demonstrate, both at the level of mRNA and at the level of cellular protein, that caveolin-1 expression in mouse macrophages is significantly affected in vitro by
LPS. However, depending on the source of macrophages, this expression
is either up- or down-regulated by LPS, most likely reflective of the
diversity of responses of macrophages to LPS stimulation in vitro.
Furthermore, regulation of cellular caveolin-1 protein expression
required LPS concentrations at least 4 orders of magnitude higher in
cells from LPS-hyporesponsive inbred mutant C3H/HeJ mice than those in
cells of LPS-responsive C3HeB/FeJ mice.
We suggest from these studies that the caveolin-1 gene product is a
potentially important cellular regulatory protein that may contribute
to cellular signaling triggered by the addition of LPS, to which the
C3H/HeJ mouse is hyporesponsive.
 |
MATERIALS AND METHODS |
C3H fibroblast cell lines.
The mouse embryonic fibroblast
cell lines SVC3H and 776-eB/FeJ, developed from the LPS-hyporesponsive
C3H/HeJ strain and the LPS-responsive C3HeB/FeJ strain, respectively,
were the generous gift of Linda R. Gooding (Department of Microbiology
and Immunology, Emory University School of Medicine, Atlanta, Ga.).
Cells were cultured with RPMI 1640 medium plus 10% fetal calf serum
(FCS), penicillin and streptomycin (each at 100 U/ml), and 2 mM
L-Glu. Upon stimulation with Escherichia coli
O111:B4 LPS (10 ng/ml), 776-eB/FeJ fibroblasts produce readily
detectable levels of IL-6 (6 ng/ml, quantitated by enzyme-linked
immunosorbent assay [ELISA] analysis of the culture supernatant using
recombinant mouse IL-6 as the standard) but, as expected, no detectable
nitric oxide. Under otherwise identical conditions (even at
significantly higher LPS concentrations), SVC3H fibroblasts produce
neither detectable IL-6 nor nitric oxide after LPS stimulation. These
results confirm that 776-eB/FeJ cells (lpsn) and
SVC3H cells (lpsd) manifest the appropriate LPS
phenotypes. E. coli O111:B4 LPS was purchased from List
Laboratories (Campbell, Calif.). Antibodies specific to mouse IL-6 and
recombinant mouse IL-6 were purchased from PharMingen (San Diego,
Calif.).
Macrophage cell lines and TG-elicited peritoneal
macrophages.
RAW264.7 and J774.1 murine macrophage-like cells
(American Type Culture Collection, Manassas, Va.) were cultured with
RPMI 1640 medium plus 10% FCS, penicillin and streptomycin (each at 100 U/ml), and 2 mM L-Glu. Primary cultures of C3H/HeJ
(lpsd) and C3HeB/FeJ
(lpsn) thioglycolate (TG)-elicited macrophages
(2) were prepared as the adherent cell population from
peritoneal exudate lavage fluid 5 days after intraperitoneal injection
of 1.5 ml of 4% Brewer TG (Difco Laboratories).
PCR-based subtractive cDNA and isolation of differentially
expressed genes.
Double-stranded cDNAs were synthesized with the
mRNAs isolated from 776-eB/FeJ (lpsn) and SVC3H
(lpsd) fibroblast cells, which were used as
"tracer" and "driver" preparations or vice versa, respectively,
as defined in the protocol (3). Two sets of subtraction,
[lpsn]0
[lpsd]0 and
[lpsd]0
[lpsn]0, were performed, thus
yielding [lpsn]1 and
[lpsd]1 preparations,
respectively. Five sequential reciprocal subtraction cycles were
performed from these two cell populations, basically by using the same
protocol as that used to prepare the first-generation subtractive cDNA,
to produce two subtractive cDNAs,
[lpsn]5 and
[lpsd]5. Thus, genes
preferentially expressed in lpsn cells to a much
greater extent than in lpsd cells were isolated
as [lpsn]5, and genes expressed
preferentially in lpsd cells to a greater extent
than in lpsn cells were isolated as
[lpsd]5. In each case the
"driver" was labeled with bio-11-dUTP (biotin-conjugated dUTP; Enzo
Diagnostics Inc.) during the PCR amplification steps. "Tracer" and
"driver" cDNAs were mixed together at a weight ratio of 1:20,
denatured, and allowed to reanneal. Driver-driver and tracer-driver
hybrids were removed by the addition of streptavidin followed by
phenol-chloroform extraction. The subtractive DNAs that were
selectively enriched by this process were then amplified by PCR, and
the process was essentially repeated until a total of 5 reciprocal
subtraction cycles were performed to obtain the enriched genes
[lpsn]5 and
[lpsd]5, which were differentially
expressed between the two cell lines. The progress of the subtractive
enrichment was evaluated by slot blot hybridization.
Our results showed that, as expected,
[lpsn]5 hybridized strongly to
itself but only very weakly to
[lpsd]5, and vice versa. The
[lpsn]5 subtractive cDNAs were
cloned in the pBluescript vector in the EcoRI cloning site,
and the [lpsd]5 subtractive cDNAs
were cloned in the pGEM-T Easy vector (Promega) by direct PCR T-A
cloning. By extensive colony hybridization and DNA dot blot
hybridization analyses, we identified 10 distinct clones from the
[lpsn]5 library and 7 clones from
the [lpsd]5 library which were
shown potentially to be differentially expressed. The insert DNAs from
these 17 clones were sequenced, and the sequences obtained were
analyzed for sequence similarity in GenBank. One clone (TB54) from the
[lpsd]5 library displayed 98%
sequence identity to murine caveolin-1 mRNA over the 267-bp cDNA
insert. Since caveolin-1 is a principal component of caveolae, and
there is now strong evidence that would implicate this gene product as
an important regulatory component of signal transduction (21,
27), and since caveolin-1 has been reported to interact with many
signaling proteins as well (6), we elected to focus
initially on this clone, TB54. Future studies will address other clones
that have been identified to be differentially expressed in
lpsn and lpsd mice.
Northern blot hybridization analysis of caveolin-1 mRNA.
A
PCR DNA product of 517 bp of the caveolin-1 coding region was used as a
probe for Northern analyses. Total RNAs of SVC3H (lpsd) and 776-eB/FeJ
(lpsn) cells were isolated with RNeasy kits
(QIAGEN). Poly(A)+ RNAs were further isolated with Oligotex
mRNA kits (QIAGEN). The isolated mRNAs of SVC3H and 776-eB/FeJ cells
(0.6 µg each) were then fractionated by agarose-formaldehyde gel
electrophoresis (26) and transferred to nylon membranes.
AlkoPhos direct labeling and CDP-Star chemifluorescent detection
systems (Amersham) were used for Northern blot hybridization analysis.
Immunoblot analysis of cellular caveolin-1 protein levels.
Total protein present in the cell lysates was separated by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), transferred to Immobilon-P membranes (Millipore), immunoblotted with
rabbit polyclonal anti-caveolin-1 antibody and horseradish peroxidase-conjugated goat anti-rabbit immunoglobulin G (IgG) (Transduction Laboratories), and detected by chemifluorescent reagents (Amersham).
 |
RESULTS |
Cloning and sequence analyses of caveolin-1 cDNA.
The TB54
plasmid DNA isolated from the
[lpsd]5 library and established to
manifest 98% sequence homology with mouse caveolin-1 in the 267-bp
insert (data not shown) was purified with a plasmid DNA purification
kit (QIAGEN), and the DNA insert was labeled with
[
-32P]ATP using the multiprime DNA labeling system
(Amersham). The labeled DNA was then used as a probe to screen the
lpsd SVC3H cDNA library constructed in the
gt22A vector (SuperScript Lambda system for cDNA library; Gibco
BRL). Four isolates were obtained.
gt11 reverse and forward primers
were used to generate PCR products of these four isolates. The PCR DNA
products of all four clones show similar sizes of about 2.5 kb. One
clone was selected for further subcloning and sequencing. Again,
gt11 forward and reverse primers were used to generate PCR products
of the insert DNA cloned in the
vector with Platinum High Fidelity Tag polymerase (Gibco BRL). The PCR DNA product was ligated
directly with the T-A cloning vector pGEM-T Easy, and the subclone
plasmid DNA, pTB548, was purified and mapped by restriction analysis. Deletion subclones were generated, and the insert DNAs were sequenced. The DNA sequence data show that the insert cDNA of TB548 has 2,482 bp,
which encodes a complete sequence of the mouse caveolin-1 gene near the
5' end of the mRNA.
Northern blot hybridization analyses of caveolin-1 mRNA.
The
caveolin-1 probe was shown to hybridize to a single mRNA band, about
2.5 kb, in both lpsn and
lpsd fibroblast cell lines but with
substantially different hybridization intensities. As demonstrated by
the data in Fig. 1, much higher levels of
expression of caveolin-1 mRNA were found in LPS-hyporesponsive SVC3H
fibroblasts than in LPS-responsive 776-eB/FeJ fibroblasts, especially
when the caveolin-1 mRNA was normalized relative to the control
-actin mRNA in the two cell preparations. These results further
confirm the previous DNA dot blot analysis finding that the caveolin-1
gene is, in fact, differentially expressed to higher levels in
LPS-hyporesponsive SVC3H cells than in LPS-responsive 776-eB/FeJ cells.
To our knowledge, this is the first report that shows a potential
relationship of LPS hyporesponsiveness and caveolin-1 hyperexpression
in endotoxin research.

View larger version (49K):
[in this window]
[in a new window]
|
FIG. 1.
Northern blot analysis of caveolin-1 in
lpsn and lpsd cells.
Isolated poly(A)+ RNAs of 776-eB/FeJ
(lpsn) and SVC3H (lpsd)
fibroblasts (0.6 µg each) were probed with the caveolin-1 gene. The
same blot was stripped and probed again with -actin as a control.
|
|
Detection of caveolin-1 mRNA in macrophages.
Macrophages are
well recognized to play a central role in host defense in response to
infection. In this respect, LPS induces both high-level cytokine
expression and NO production and also regulates surface receptor
expression in macrophages. Since the question of expression of
caveolin-1 in mouse macrophages is currently considered somewhat
controversial (17-19, 32), it would, of course, be
important to clarify whether mouse macrophages even express caveolin-1
mRNA. We first synthesized a reverse primer, p1 (5'-GGG AGA ACA GAC ATG
TCT TG-3' and a forward primer, p2 (5'-TAC GAT CTT CGG CAT CCC AAT-3'),
that frame 1,957 bp of the caveolin-1 cDNA. Using this primer pair, we
obtained almost exactly the predicted size of the DNA product by
reverse transcription (RT)-PCR with total RNAs isolated from both the
RAW264.7 and the J774.1 macrophage-like cell lines, as well as from
primary TG-elicited peritoneal macrophages of C3HeB/FeJ
(lpsn) and C3H/HeJ (lpsd)
mice (data not shown). These RT-PCR products are very similar in size
to those found in the fibroblast cell lines (data not shown). In
addition to the 1,957-bp PCR product, however, we also obtained a DNA
product of about 1,300 bp with primers p1 and p2 in all cells except in
J774.1. We have cloned this 1,300-bp DNA fragment from SVC3H cells, and
DNA sequence analysis shows that the 1,300-bp DNA fragment also codes
for caveolin-1, with the sequence truncated at a position downstream of
the primary caveolin-1 coding sequence. It is possible that the mRNA
coding for the 1,300-bp RT-PCR DNA product may be the product of some
posttranscriptional modification events.
Effect of LPS on caveolin-1 expression in RAW264.7 cells.
Since caveolin-1 message was readily detected in virtually all of the
mouse macrophage populations tested, we investigated further whether
LPS stimulation can affect caveolin-1 mRNA expression in these cells.
RAW264.7 is one of the most widely used murine macrophage-like cell
lines that has been investigated in studies of LPS stimulation. To
determine whether caveolin-1 mRNA levels can be modified in the
presence of LPS, RAW264.7 cells were cultured in 6-well plates (5 × 105 cells per well) overnight and then incubated with
LPS (100 ng/ml) for periods of time from 2 to 24 h. Total RNA in
each well after LPS stimulation was prepared with Trizol reagent (Gibco
BRL). Caveolin-1 message was then analyzed by RT-PCR with primers p1 and p2. The results of these experiments show that, after incubation of
RAW264.7 cells with LPS for 15 to 24 h, mRNA levels were markedly reduced compared to those obtained without LPS stimulation. The results
of LPS down-regulation of caveolin message were confirmed by individual
post-LPS-stimulation time course experiments (Fig. 2). It is also of interest that the
decrease in levels of the truncated caveolin-1 message (the 1,300-bp
PCR product) is also time dependent in RAW264.7 cells and is observed
both in the presence and in the absence of LPS stimulation, with
perhaps an even more rapid rate of decrease in the presence of LPS
relative to the untreated control cells. The significance of this
observation is unclear at present.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 2.
Effect of LPS on caveolin-1 expression in RAW264.7
cells. RAW264.7 cells were incubated with 100 ng of LPS/ml for various
lengths of time. Total RNAs were isolated with Trizol reagent. Equal
amounts of total RNAs were reverse transcribed using
oligo(dT)16 as the primer. The caveolin-1-specific primers
p1 and p2 were used in PCR amplification. Equal amounts of PCR products
were subjected to agarose gel electrophoresis.
|
|
To further investigate the effect of LPS on caveolin-1 at the protein
level, RAW264.7 cells were incubated with LPS to determine
both the
time course (4 to 24 h at 100 ng of LPS/ml) (Fig.
3A)
and the concentration dependence (0 to 100 ng of LPS/ml for 24
h) (Fig.
3B) by immunoblotting with
anti-caveolin-1 antibody.
We found that the levels of caveolin-1
protein in RAW264.7 cells
were also, as expected, substantially reduced
in the total-cell
lysate after stimulation of these cells with LPS, in
both a time-
and a dose-dependent manner. The results of the immunoblot
studies
strongly support the conclusion that cellular caveolin-1 levels
can be highly regulated by LPS stimulation in RAW264.7 cells.

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 3.
Effect of LPS on caveolin-1 protein expression. RAW264.7
cells were incubated with 100 ng of LPS/ml for 4 to 24 h (A) or
with 1 to 100 ng of LPS/ml for 24 h (B). Equal volumes of
total-cell lysates (20 µg of protein per sample) were subjected to
SDS-PAGE, transferred to Immobilon-P membranes, and analyzed by
immunoblotting using rabbit anti-caveolin-1 antibody and horseradish
peroxidase-conjugated goat anti-rabbit IgG. The immunoblots were
developed by enhanced chemifluorescence. The protein concentrations in
each cell lysate were comparable as analyzed by bicinchoninic acid
reagents (Pierce).
|
|
Effect of LPS on caveolin-1 expression in TG-elicited peritoneal
macrophages.
We have also investigated whether LPS affects
caveolin-1 mRNA expression in primary cultures of TG-elicited mouse
peritoneal macrophages. Cells were plated in 6-well plates at 2 × 106 cells/well and incubated at 37°C for 2 h.
Nonadherent cells were removed by gentle washing, and the remaining
adherent cells were incubated with LPS at 1.0 pg/ml to 10 ng/ml for
6 h for concentration-dependent studies (Fig.
4), and with LPS at 10 ng/ml for 15 min
to 6 h for time-dependent studies (Fig.
5). The expression of caveolin-1 protein
was analyzed by immunoblotting with anti-caveolin-1 antibody as
described for Fig. 3. The results show that, in LPS-responsive primary
macrophages of C3HeB/FeJ origin, caveolin-1 protein expression was
highly up-regulated at test concentrations as low as 1.0 pg of LPS/ml.
However, LPS concentrations at least 4 orders of magnitude higher
(104 pg/ml) were required to stimulate the
LPS-hyporesponsive primary macrophages of C3H/HeJ origin (Fig. 4) to
manifest even a modestly significant increase in cellular caveolin-1
expression. The results of time-dependent studies also show that at 10 ng of LPS/ml, the up-regulation of caveolin-1 protein levels in
C3HeB/FeJ peritoneal macrophages could be detected 2 h post-LPS
treatment, while that in C3H/HeJ peritoneal macrophages was detected 4 to 6 h post-LPS treatment (Fig. 5). The results of these
immunoblot studies show clearly that caveolin-1 protein levels in
lpsn primary macrophages are regulated by LPS
even at extremely low LPS concentrations (e.g., 1.0 pg/ml) but that
regulation in C3H/HeJ macrophages is markedly less sensitive.

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 4.
Dose-dependent effect of LPS on caveolin-1 protein
expression in TG-elicited peritoneal macrophages prepared from C3H/HeJ
and C3HeB/FeJ mice. Cells were incubated with LPS at 1.0 pg/ml to 10 ng/ml for 6 h. Cellular caveolin-1 protein levels were analyzed by
immunoblotting with anti-caveolin-1 antibody as described for Fig. 3.
|
|

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 5.
Time-dependent effect of LPS on caveolin-1 protein
expression in TG-elicited peritoneal macrophages prepared from C3H/HeJ
and C3HeB/FeJ mice. Cells were incubated with 10 ng of LPS/ml for 15 min to 6 h. Caveolin-1 protein expression was analyzed by
immunoblotting as described for Fig. 3.
|
|
We initially determined by RT-PCR analyses that caveolin-1 mRNA levels
in primary cultures of TG-elicited peritoneal macrophages
of C3HeB/FeJ
mice, but not in those of C3H/HeJ mice, were up-regulated
by LPS
stimulation at 25 to 100 ng/ml after 16 h of incubation
(data not
shown). However, the above results (Fig.
4 and
5) show
that cellular
caveolin-1 protein levels were affected by LPS at
much lower
concentrations and at earlier times. We therefore further
studied the
effect of LPS on caveolin-1 mRNA expression at the
same LPS
concentrations and time course as described for Fig.
4 and
5 by RT-PCR
analyses. The results of these studies are shown
in Fig.
6 and
7 for
concentration- and time-dependent experiments,
respectively. Although
the results of RT-PCR analysis for the
up-regulation of caveolin-1
expression by LPS were found not to
be as marked as the protein
immunoblot data shown in Fig.
4 and
5, they clearly confirm detectable
up-regulation of both the 1,957-
and 1,300-bp PCR products, reflecting
the regulation of caveolin-1
mRNA expression in primary cultures of
lpsn TG-elicited peritoneal macrophages by LPS.
It is of potential
interest, once again, that the truncated caveolin-1
message that
produces the 1,300-bp PCR product appears to be more
sensitive
to LPS-dependent regulation than the message that produces
the
1,957-bp PCR product. In contrast, we have observed little
detectable
change in levels of either caveolin-1 mRNA in primary
cultures
of C3H/HeJ macrophages in response to LPS.

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 6.
Dose-dependent effect of LPS on caveolin-1 mRNA
expression in elicited peritoneal macrophages. TG-elicited peritoneal
macrophages were prepared and treated with LPS at 1 pg/ml to 10 ng/ml
for 6 h. Caveolin-1 mRNA expression was analyzed by RT-PCR as
described for Fig. 2.
|
|

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 7.
Time-dependent effect of LPS on caveolin-1 mRNA
expression in elicited peritoneal macrophages. TG-elicited peritoneal
macrophages were prepared and treated with 10 ng of LPS/ml for 15 min
to 6 h. Caveolin-1 mRNA expression was analyzed by RT-PCR as
described for Fig. 2.
|
|
 |
DISCUSSION |
The findings summarized in Results show differential expression of
caveolin-1 in lpsn and
lpsd fibroblasts and indicate that expression of
this gene and gene product can be markedly up-regulated by LPS in
primary cultures of TG-elicited peritoneal macrophages of
lpsn mice, but not of
lpsd mice, at extremely low concentrations of
LPS. Importantly, the effect of LPS on caveolin-1 in C3HeB/FeJ
macrophages is totally different from that observed in RAW264.7 cells.
These results indicate that the effects of LPS stimulation on
caveolin-1 expression differ not only between
lpsn and lpsd cells, but
also among lpsn cells from different sources.
These findings support the concept that caveolin-1 may well serve as
one of the important cellular contributing factors that ultimately
dictate the well-recognized diverse phenotypic responses of macrophages
to LPS stimulation.
In recent studies, Wang et al. (32) and Kitchens et al.
(18) reported that, in CD14-expressing THP-1 and normal
human monocytes, glycosylphosphatidylinositol (GPI)-anchored
CD14- dependent internalization of LPS appears to occur
predominantly via non-clathrin-coated "caveola-like" plasma
membrane invaginations. The authors indicated, however, that in THP-1
cells, membrane invaginations were more "tubular" in structure than
were classical "flask-shaped" caveolae. These investigators
nevertheless cautioned that these cells might not contain caveolae.
However, Matveev et al. (19) have reported that caveolin-1
is associated with cholesteryl ester uptake in THP-1 macrophages. Kiss
and Geuze (17), using antibody against caveolin-1, found
that caveolae, the omega-shaped plasma membrane invaginations, were
abundantly present in the plasma membranes of elicited rat peritoneal
macrophages. They also found that, in elicited macrophages, caveolae
could be observed to "pinch off" from the plasma membrane. Based on
those findings, these authors suggested that caveolae might well
function as alternative carriers in endocytotic processes of these
cells. Very recently, caveolin-1 has been suggested to serve a primary
role in organizing "preassembled signaling complexes" at the plasma
membrane (21). Collectively, these results, when considered
within the framework of our own studies reported here showing major
effects of LPS on cellular caveolin-1 expression, strongly support the
conclusion that caveolae, and more specifically caveolin-1, may well be
involved as critical regulatory components in cellular responses to
LPS, leading to signaling and/or internalization in mouse macrophages.
While there is no question but that the mutational defect in TLR4 in
C3H/HeJ mice, affecting innate LPS recognition, is highly important in
the regulation of LPS cellular triggering events, it remains
inconclusive in terms of full manifestation of the lpsd phenotype (31). Our new findings
that caveolin-1 is differentially expressed in LPS-responsive and
-hyporesponsive cells tend to support the conclusion that the C3H/HeJ
defect may also be affected by gene products other than TLR4, a
conclusion that has a solid scientific basis in the recently published
studies of Vogel et al. (31). It is of some interest that
Toll-like receptor 2 (TLR2) was also identified as a potential membrane
receptor/transducer for LPS signal transduction in
tlr2-transfected human embryonic kidney cells (16,
35). While this may well be true in appropriately transfected
cells, Heine et al. (10) reported that expression of
functional TLR2 would not be essential for the LPS-sensitive CD14-transfected Chinese hamster ovary fibroblast response to LPS. More
recently, Underhill et al. (30) demonstrated that in
macrophages, TLR2 primarily mediates signals from yeast and gram-positive bacteria, but not from gram-negative bacteria and LPS.
As pointed out above, caveolin-1, a dynamic integral membrane protein,
has been shown to interact with, and to suppress, the activities of
various signaling proteins (6, 7, 21) and has been suggested
as a possible candidate for a tumor suppressor gene (7). We
have found that cellular caveolin-1 levels are significantly higher in
LPS-hyporesponsive fibroblasts than in LPS-responsive fibroblasts.
Although many studies have demonstrated that LPS regulates the
expression of many genes, our data show for the first time that LPS
regulates caveolin-1 expression levels in normal LPS-responsive mouse
macrophages. Taken together, therefore, these studies suggest a
potentially important role for this protein in regulating host
responsiveness to LPS.
We hypothesize, based upon these findings, that molecular regulation of
caveolin-1 gene expression may serve as a "gatekeeper" in defining
the specific consequences of interactions of LPS with LPS receptors at
the macrophage surface membrane (i.e., cellular internalization versus
signaling) that will ultimately define the phenotypic response of this
host immune-inflammatory cell to LPS and probably to gram-negative,
LPS-containing microbes as well. The potentially differential roles of
the two caveolin-1 messages observed in these studies, one producing a
1,957-bp PCR product and the other a truncated 1,300-bp PCR product,
also may well merit additional investigation. In any case, these
findings add to the complexity of the pathways that dictate both
triggering and regulation of LPS-mediated events in host
immune-inflammatory cell responses.
 |
ACKNOWLEDGMENTS |
This work was supported by NIH grant R37AI23447.
We authors thank Eleanor Zuvanich and Wei Cui, Jiangjun Gao, and Fuan
Wang for helping with the preparation of macrophages, and we thank
Alexander Shnyra and John Gray for constructive advice in the
preparation of figures. Special thanks are extended to Chia Y. Lee for
helpful discussions in the course of this work.
 |
FOOTNOTES |
*
Corresponding author. Present address: Department of
Basic Medical Science, University of Missouri at Kansas City, School of
Medicine, Kansas City, MO 64108. Phone: (816) 235-6067. Fax: (816)
235-5527. E-mail: leim{at}umkc.edu.
Editor:
R. N. Moore
 |
REFERENCES |
| 1.
|
Akashi, S.,
R. Shimazu,
H. Ogata,
Y. Nagai,
K. Takeda,
M. Kimoto, and K. Miyake.
2000.
Cell surface expression and lipopolysaccharide signaling via the Toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages.
J. Immunol.
164:3471-3475[Abstract/Free Full Text].
|
| 2.
|
Amura, C. R.,
L.-C. Chen,
N. Hirohashi,
M.-G. Lei, and D. C. Morrison.
1997.
Two functionally independent pathways for lipopolysaccharide-dependent activation of mouse peritoneal macrophages.
J. Immunol.
159:5079-5083[Abstract].
|
| 3.
|
Ausubel, F. M.,
R. E. Kingston,
J. G. Seidman,
K. Struhl,
D. D. Moore,
R. Brent, and J. A. Smith (ed.).
1999.
Current protocols in molecular biology.
John Wiley and Sons, Inc., New York, N.Y.
|
| 4.
|
Brooke, M. S.
1965.
Conversion of immunological paralysis to immunity by endotoxin.
Nature
206:635-636[CrossRef][Medline].
|
| 5.
|
Chow, J. C.,
D. W. Young,
D. T. Golenbock,
W. J. Crist, and F. Gusovsky.
1999.
Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction.
J. Biol. Chem.
274:10689-10692[Abstract/Free Full Text].
|
| 6.
|
Couet, J.,
M. Sargiacomo, and M. P. Lisanti.
1997.
Interaction of a receptor tyrosine kinase, EGF-R, with caveolin. Caveolin binding negatively regulates tyrosine and serine/threoline kinase activities.
J. Biol. Chem.
272:30429-30438[Abstract/Free Full Text].
|
| 7.
|
Engelman, J. A.,
X. L. Zhang,
F. Galbiati, and M. P. Lisanti.
1998.
Chromosomal localization, genomic organization, and developmental expression of the murine caveolin gene family (Cav-1, -2, and -3).
FEBS Lett.
429:330-336[CrossRef][Medline].
|
| 8.
|
Glenney, J. R., Jr., and D. Soppet.
1992.
Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts.
Proc. Natl. Acad. Sci. USA
89:10517-10521[Abstract/Free Full Text].
|
| 9.
|
Goodman, S. A., and D. C. Morrison.
1985.
Lipopolysaccharide receptors on lymphocytes. I. Lack of immunologic recognition of a putative LPS receptor on LPS-responder lymphocytes by LPS-nonresponder mice.
J. Immunol.
135:1906-1910[Abstract].
|
| 10.
|
Heine, H.,
C. J. Kirschning,
E. Lien,
B. G. Monks,
M. Rothe, and D. T. Golenbock.
1999.
Cells that carry a null allele for Toll-like receptor 2 are capable of responding to endotoxin.
J. Immunol.
162:6971-6975[Abstract/Free Full Text].
|
| 11.
|
Hoffmann, J. A.,
F. C. Kafatos,
C. A. Janeway, Jr., and R. A. B. Ezekowitz.
1999.
Phylogenetic perspectives in innate immunity.
Science
284:1313-1318[Abstract/Free Full Text].
|
| 12.
|
Hoshino, K.,
O. Takeuchi,
T. Kawai,
H. Sanjo,
T. Ogawa,
Y. Takeda,
K. Takeda, and S. Akira.
1999.
Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product.
J. Immunol.
162:3749-3752[Abstract/Free Full Text].
|
| 13.
|
Jin, F.-Y.,
C. Nathan,
D. Radzioch, and A. Ding.
1997.
Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide.
Cell
88:417-426[CrossRef][Medline].
|
| 14.
|
Jin, F.-Y.,
C. F. Nathan, and A. Ding.
1999.
Paradoxical preservation of a lipopolysaccharide response in C3H/HeJ macrophages: induction of matrix metalloproteinase-9.
J. Immunol.
162:3596-3600[Abstract/Free Full Text].
|
| 15.
|
Kang, A. D.,
P. M. C. Wong,
H. Chen,
R. Castagan,
S.-W. Chung, and B. M. Sultzer.
1996.
Restoration of lipopolysaccharide-mediated B-cell response after expression of a cDNA encoding a GTP-binding protein.
Infect. Immun.
64:4612-4617[Abstract].
|
| 16.
|
Kirschning, C. J.,
H. Wesche,
T. M. Ayres, and M. Rothe.
1998.
Human Toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide.
J. Exp. Med.
188:2091-2097[Abstract/Free Full Text].
|
| 17.
|
Kiss, A. L., and H. J. Geuze.
1997.
Caveolae can be alternative endocytotic structures in elicited macrophages.
Eur. J. Cell. Biol.
73:19-27[Medline].
|
| 18.
|
Kitchens, R. L.,
P.-Y. Wang, and R. S. Munford.
1998.
Bacterial lipopolysaccharide can enter monocytes via two CD14-dependent pathways.
J. Immunol.
161:5534-5545[Abstract/Free Full Text].
|
| 19.
|
Matveev, S.,
D. R. van der Westhuyzen, and E. J. Smart.
1999.
Co-expression of scavenger receptor-B1 and caveolin-1 is associated with enhanced selective cholesteryl ester uptake in THP-1 macrophages.
J. Lipid Res.
40:1647-1654[Abstract/Free Full Text].
|
| 20.
|
Nomura, F.,
S. Akashi,
Y. Sakao,
S. Sato,
T. Kawai,
M. Matsumoto,
K. Nakanishi,
M. Kimoto,
K. Miyake,
T. Takeda, and S. Akira.
2000.
Endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface Toll-like receptor 4 expression.
J. Immunol.
164:3476-3479[Abstract/Free Full Text].
|
| 21.
|
Okamato, T.,
A. Schlegel,
P. E. Scherer, and M. P. Lisanti.
1998.
Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane.
J. Biol. Chem.
273:5419-5422[Free Full Text].
|
| 22.
|
Poltorak, A.,
X. He,
I. Smirnova,
M.-Y. Liu,
C. van Huffel,
X. Du,
D. Birdwell,
E. Alejos,
M. Silva,
C. Galanos,
M. Freudenberg,
P. Ricciardi-Castagnoli,
B. Layton, and B. Beutler.
1998.
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutation in Tlr4 gene.
Science
282:2085-2088[Abstract/Free Full Text].
|
| 23.
|
Qureshi, S. T.,
L. Larivière,
G. Leveque,
S. Clermont,
K. J. Moore,
P. Gros, and D. Malo.
1999.
Endotoxin-tolerant mice have mutation in Toll-like receptor 4 (Tlr4).
J. Exp. Med.
189:615-625[Abstract/Free Full Text].
|
| 24.
|
Rosenstreich, D. L.
1985.
Genetic control of endotoxin response: C3H/HeJ mouse, p. 82-122.
In
L. J. Berry (ed.), Handbook of endotoxin, vol. 3. Cellular biology of endotoxin. Elsevier Science Publishers, Amsterdam, The Netherlands.
|
| 25.
|
Rothberg, K. G.,
J. E. Houser,
W. C. Donzell,
Y.-S. Ying,
J. R. Glenney, and R. G. W. Anderson.
1992.
Caveolin, a protein component of caveolae membrane coats.
Cell
68:673-682[CrossRef][Medline].
|
| 26.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 27.
|
Shaul, P. W., and R. G. W. Anderson.
1998.
Role of plasmalemmal caveolae in signal transduction.
Am. J. Physiol.
275:L843-L851[Abstract/Free Full Text].
|
| 28.
|
Sultzer, B. M.
1968.
Genetic control of leukocyte responses to endotoxin.
Nature
219:1253-1254[CrossRef][Medline].
|
| 29.
|
Tang, Z. L.,
T. Okamoto,
P. Boontrakulpoontawee,
T. Katada,
A. J. Otsuka, and M. P. Lisanti.
1997.
Identification, sequence, and expression of an invertebrate caveolin gene family from the nematode Caenorhabditis elegans.
J. Biol. Chem.
272:2437-2445[Abstract/Free Full Text].
|
| 30.
|
Underhill, D. M.,
A. Ozinsky,
A. M. Hajjar,
A. Stevens,
C. B. Wilson,
M. Bassetti, and A. Aderem.
1999.
The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens.
Nature
401:811-815[CrossRef][Medline].
|
| 31.
|
Vogel, S. N.,
D. Johnson,
P.-Y. Perera,
A. Medvedev,
L. Larivière,
S. T. Qureshi, and D. Malo.
1999.
Functional characterization of the effect of the C3H/HeJ defect in mice that lack an Lpsn gene: in vivo evidence for a dominant negative mutation.
J. Immunol.
162:5666-5670[Abstract/Free Full Text].
|
| 32.
|
Wang, P.-Y.,
R. L. Kitchens, and R. S. Munford.
1996.
Bacterial lipopolysaccharide binds to low-density domains of the monocyte-macrophage plasma membrane.
J. Inflamm.
47:126-137.
|
| 33.
|
Wong, P. M. C.,
A. Kang,
H. Chen,
Q. Yuan,
P. Fan,
B. M. Sultzer,
Y. W. Kan, and S.-W. Chung.
1999.
Lpsd/Ran of endotoxin-resistant C3H/HeJ mice is defective in mediating lipopolysaccharide endotoxin responses.
Proc. Natl. Acad. Sci. USA
96:11543-11548[Abstract/Free Full Text].
|
| 34.
|
Watson, J.,
K. Kelly,
M. Largen, and B. A. Taylor.
1978.
The genetic mapping of a defective LPS response gene in C3H/HeJ mice.
J. Immunol.
120:422-424[Abstract/Free Full Text].
|
| 35.
|
Yang, R. B.,
M. R. Mark,
A. Gray,
M. H. Xie,
M. Zhang,
A. Goddard,
W. I. Wood,
A. L. Gurney, and H. J. Godowski.
1998.
Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signaling.
Nature
395:284-288[CrossRef][Medline].
|
Infection and Immunity, September 2000, p. 5084-5089, Vol. 68, No. 9
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Tiruppathi, C., Shimizu, J., Miyawaki-Shimizu, K., Vogel, S. M., Bair, A. M., Minshall, R. D., Predescu, D., Malik, A. B.
(2008). Role of NF-{kappa}B-dependent Caveolin-1 Expression in the Mechanism of Increased Endothelial Permeability Induced by Lipopolysaccharide. J. Biol. Chem.
283: 4210-4218
[Abstract]
[Full Text]
-
Hu, G., Ye, R. D., Dinauer, M. C., Malik, A. B., Minshall, R. D.
(2008). Neutrophil caveolin-1 expression contributes to mechanism of lung inflammation and injury. Am. J. Physiol. Lung Cell. Mol. Physiol.
294: L178-L186
[Abstract]
[Full Text]
-
Medina, F. A., de Almeida, C. J., Dew, E., Li, J., Bonuccelli, G., Williams, T. M., Cohen, A. W., Pestell, R. G., Frank, P. G., Tanowitz, H. B., Lisanti, M. P.
(2006). Caveolin-1-Deficient Mice Show Defects in Innate Immunity and Inflammatory Immune Response during Salmonella enterica Serovar Typhimurium Infection. Infect. Immun.
74: 6665-6674
[Abstract]
[Full Text]
-
Wang, X. M., Kim, H. P., Song, R., Choi, A. M. K.
(2006). Caveolin-1 Confers Antiinflammatory Effects in Murine Macrophages via the MKK3/p38 MAPK Pathway. Am. J. Respir. Cell Mol. Bio.
34: 434-442
[Abstract]
[Full Text]
-
Lei, M. G., Tan, X., Qureshi, N., Morrison, D. C.
(2005). Regulation of Cellular Caveolin-1 Protein Expression in Murine Macrophages by Microbial Products. Infect. Immun.
73: 8136-8143
[Abstract]
[Full Text]
-
Ohnuma, K., Yamochi, T., Uchiyama, M., Nishibashi, K., Iwata, S., Hosono, O., Kawasaki, H., Tanaka, H., Dang, N. H., Morimoto, C.
(2005). CD26 Mediates Dissociation of Tollip and IRAK-1 from Caveolin-1 and Induces Upregulation of CD86 on Antigen-Presenting Cells. Mol. Cell. Biol.
25: 7743-7757
[Abstract]
[Full Text]
-
Llaverias, G., Vazquez-Carrera, M., Sanchez, R. M., Noe, V., Ciudad, C. J., Laguna, J. C., Alegret, M.
(2004). Rosiglitazone upregulates caveolin-1 expression in THP-1 cells through a PPAR-dependent mechanism. J. Lipid Res.
45: 2015-2024
[Abstract]
[Full Text]
-
Ohnuma, K., Yamochi, T., Uchiyama, M., Nishibashi, K., Yoshikawa, N., Shimizu, N., Iwata, S., Tanaka, H., Dang, N. H., Morimoto, C.
(2004). CD26 up-regulates expression of CD86 on antigen-presenting cells by means of caveolin-1. Proc. Natl. Acad. Sci. USA
101: 14186-14191
[Abstract]
[Full Text]
-
KIM, H. P., WANG, X., GALBIATI, F., RYTER, S. W., CHOI, A. M. K.
(2004). Caveolae compartmentalization of heme oxygenase-1 in endothelial cells. FASEB J.
18: 1080-1089
[Abstract]
[Full Text]
-
Navarro-Lerida, I., Portoles, M. T., Barrientos, A. A., Gavilanes, F., Bosca, L., Rodriguez-Crespo, I.
(2004). Induction of nitric oxide synthase-2 proceeds with the concomitant downregulation of the endogenous caveolin levels. J. Cell Sci.
117: 1687-1697
[Abstract]
[Full Text]
-
Gargalovic, P., Dory, L.
(2003). Cellular apoptosis is associated with increased caveolin-1 expression in macrophages. J. Lipid Res.
44: 1622-1632
[Abstract]
[Full Text]
-
Qureshi, N., Perera, P.-Y., Shen, J., Zhang, G., Lenschat, A., Splitter, G., Morrison, D. C., Vogel, S. N.
(2003). The Proteasome as a Lipopolysaccharide-Binding Protein in Macrophages: Differential Effects of Proteasome Inhibition on Lipopolysaccharide-Induced Signaling Events. J. Immunol.
171: 1515-1525
[Abstract]
[Full Text]
-
Gargalovic, P., Dory, L.
(2003). Caveolins and macrophage lipid metabolism. J. Lipid Res.
44: 11-21
[Abstract]
[Full Text]
-
Llano, M., Kelly, T., Vanegas, M., Peretz, M., Peterson, T. E., Simari, R. D., Poeschla, E. M.
(2002). Blockade of Human Immunodeficiency Virus Type 1 Expression by Caveolin-1. J. Virol.
76: 9152-9164
[Abstract]
[Full Text]
-
Ganta, R. R., Wilkerson, M. J., Cheng, C., Rokey, A. M., Chapes, S. K.
(2002). Persistent Ehrlichia chaffeensis Infection Occurs in the Absence of Functional Major Histocompatibility Complex Class II Genes. Infect. Immun.
70: 380-388
[Abstract]
[Full Text]
-
Vogel, S. N.
(2000). Lps: another piece in the puzzle. Innate Immunity
6: 295-300
-
Gargalovic, P., Dory, L.
(2001). Caveolin-1 and Caveolin-2 Expression in Mouse Macrophages. HIGH DENSITY LIPOPROTEIN 3-STIMULATED SECRETION AND A LACK OF SIGNIFICANT SUBCELLULAR CO-LOCALIZATION. J. Biol. Chem.
276: 26164-26170
[Abstract]
[Full Text]